Cellebrite DI Ltd.
CLBT
$13.18
$0.010.08%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 10.34% | 181.79% | 124.38% | 231.56% | |
| Total Depreciation and Amortization | 44.41% | 0.62% | -1.83% | 4.36% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 281.06% | -90.40% | -93.43% | -89.11% | |
| Change in Net Operating Assets | 17.63% | 230.69% | 3.33% | 87.94% | |
| Cash from Operations | 31.60% | 124.51% | 107.93% | 50.51% | |
| Capital Expenditure | -24.48% | -74.05% | -56.45% | -40.62% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -641.52% | 241.66% | -55.01% | -335.58% | |
| Cash from Investing | -1,443.11% | 221.98% | -55.04% | -604.56% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -65.23% | 315.94% | -28.59% | 48.57% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -65.23% | 315.94% | -28.59% | 48.57% | |
| Foreign Exchange rate Adjustments | 103.89% | 3,695.92% | 237.00% | -254.29% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -383.68% | 673.46% | -50.83% | 5.45% | |